Eli Lilly’s Mounjaro is projected to be the best-selling drug in the world in 2030, according to Statista data shared March 9 with Becker’s.
Statista is a global data company that provides market insights for 170 industries, including pharmaceuticals.
The company projects these 10 drugs will be the best-selling pharmaceutical products worldwide in 2030:
1. Mounjaro, a Type 2 diabetes medication
Manufacturer: Eli Lilly
Projected global sales in 2030: $36.2 billion
2. Skyrizi, a therapy for plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis
Manufacturer: AbbVie
Projected global sales in 2030: $26.6 billion
3. Zepbound, a GLP-1 for obesity and sleep apnea
Manufacturer: Eli Lilly
Projected global sales in 2030: $25.5 billion
4. Dupixent, a therapy for nine chronic inflammatory conditions
Manufacturer: Sanofi/Regeneron
Projected global sales in 2030: $25.1 billion
5. Ozempic, a GLP-1 for Type 2 diabetes, cardiovascular disease and kidney disease
Manufacturer: Novo Nordisk
Projected global sales in 2030: $24.4 billion
6. Wegovy, a GLP-1 for obesity, cardiovascular disease and kidney disease
Manufacturer: Novo Nordisk
Projected global sales in 2030: $18.1 billion
7. Keytruda, a therapy for about a dozen cancers
Manufacturer: Merck
Projected global sales in 2030: $16.9 billion
8. Darzalex, a multiple myeloma therapy
Manufacturer: Johnson & Johnson/Genmab
Projected global sales in 2030: $16.6 billion
9. Biktarvy, an HIV-1 treatment
Manufacturer: Gilead
Projected global sales in 2030: $15.7 billion
10. CagriSema, an experimental GLP-1 drug for weight loss
Manufacturer: Novo Nordisk
Projected global sales in 2030: $15.2 billion
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
